| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 08/20/2013 | US8512533 Biosensor, biosensor package structure having same, and method for fabricating same |
| 08/20/2013 | US8512532 Method of producing whole blood detecting electrode strip and reaction film formulation and the related products |
| 08/20/2013 | US8512239 Glucose measuring device for use in personal area network |
| 08/20/2013 | US8511147 Analyte sensors and methods of use |
| 08/20/2013 | US8511145 Explosive event discrimination |
| 08/20/2013 | US8511139 Systems and methods for impact testing |
| 08/20/2013 | CA2582578C Simultaneous sequence analysis of amino- and carboxy- termini |
| 08/20/2013 | CA2582470C Compartmentalised combinatorial chemistry by microfluidic control |
| 08/20/2013 | CA2579186C Method for production of a multi-layer analysis element |
| 08/20/2013 | CA2571730C Analysis of intracellular modifications |
| 08/20/2013 | CA2516563C Methods of preventing, treating and diagnosing disorders of protein aggregation |
| 08/20/2013 | CA2505509C Method and probes for the detection of a tumor specific fusion protein |
| 08/20/2013 | CA2504953C A new target for angiogenesis and anti-angiogenesis therapy |
| 08/20/2013 | CA2492333C Canine respiratory coronavirus (crcv) spike protein, polymerase and hemagglutinin/esterase |
| 08/20/2013 | CA2487824C Oncolytic viruses as phenotyping agents for neoplasms |
| 08/20/2013 | CA2440358C Denaturant stable and/or protease resistant, chaperone-like oligomeric proteins, polynucleotides encoding same and their uses |
| 08/20/2013 | CA2429180C Discordant helix stabilization for prevention of amyloid formation |
| 08/15/2013 | WO2013120114A1 Risk factors and prediction of adverse events |
| 08/15/2013 | WO2013120099A1 Nmr-based metabolite screening platform |
| 08/15/2013 | WO2013120089A1 Molecular diagnostic screening assay |
| 08/15/2013 | WO2013120086A1 Inhibition of the glycine cleavage system for treatment of cancer |
| 08/15/2013 | WO2013120018A1 Methods and compositions for screening and treating developmental disorders |
| 08/15/2013 | WO2013119990A2 Detection and treatment of cd30+ cancers |
| 08/15/2013 | WO2013119986A1 Methods for measuring high molecular weight complexes of fibrinogen with fibronectin and fibulin-1 |
| 08/15/2013 | WO2013119893A1 Assays for the identification of compounds that modulate osteoblast function and bone formation |
| 08/15/2013 | WO2013119871A1 A multi-biomarker-based outcome risk stratification model for pediatric septic shock |
| 08/15/2013 | WO2013119869A1 A multi-biomarker-based outcome risk stratification model for adult septic shock |
| 08/15/2013 | WO2013119793A1 Chemiluminescent nanoparticles and uses thereof |
| 08/15/2013 | WO2013119771A1 Methods of screening for activation deaminase inhibitors through nuclear import inhibitors |
| 08/15/2013 | WO2013119765A1 Devices with fluidic nanofunnels, associated methods, fabrication and analysis systems |
| 08/15/2013 | WO2013119763A1 Mycobacterium tuberculosis specific peptides for detection of infection or immunization in non-human primates |
| 08/15/2013 | WO2013119729A1 Sample collection and transport devices, methods, and kits |
| 08/15/2013 | WO2013119719A1 Microprocessor-controlled microfluidic platform for pathogen, toxin, biomarker, and chemical detection with removable updatable sensor array for food and water safety, medical, and laboratory apllications |
| 08/15/2013 | WO2013119684A1 Methods and materials for identifying mammals having prostate cancer |
| 08/15/2013 | WO2013119678A1 Lkb1/stk11 deletion in melanoma and related methods |
| 08/15/2013 | WO2013119673A1 Innate immune proteins as biomarkers for cns injury |
| 08/15/2013 | WO2013119579A1 Detection of intracellular binding events by measuring protein abundance |
| 08/15/2013 | WO2013119377A1 Autophagy-inducing peptide |
| 08/15/2013 | WO2013119312A1 Method of identifying an agent for inhibiting odor of pyrazine derivatives |
| 08/15/2013 | WO2013119282A1 Apparatus and system for a vortex three port container |
| 08/15/2013 | WO2013119279A2 Assays and methods for the diagnosis of ovarian cancer |
| 08/15/2013 | WO2013119228A1 Gas-phase delivery system for molecule sensing apparatus |
| 08/15/2013 | WO2013119114A1 Protein target complex |
| 08/15/2013 | WO2013119111A1 Cell death assay |
| 08/15/2013 | WO2013118960A1 Hemolysis reagent composition for hemoglobin a1c quantitative analysis using enzymatic method |
| 08/15/2013 | WO2013117930A2 Diagnosing multiple sclerosis |
| 08/15/2013 | WO2013117916A1 Apparatus for administering fluid to a medical tube |
| 08/15/2013 | WO2013117880A1 Formulation and method for the printing of biological materials |
| 08/15/2013 | WO2013117763A1 Compounds and methods for the diagnosis of babesia canis canis infection |
| 08/15/2013 | WO2013117747A1 A device and method for non-invasive analysis of particles during medical ventilation |
| 08/15/2013 | WO2013117746A1 Signatures and determinants for diagnosing infections and methods of use thereof |
| 08/15/2013 | WO2013117697A1 Biomarker set for identifying a severe form of cancer |
| 08/15/2013 | WO2013117681A1 Assay and method for determining insulin-resistance |
| 08/15/2013 | WO2013117624A1 Method for obtaining three-dimensional actin structures and uses thereof |
| 08/15/2013 | WO2013117618A1 Process for evaluating active agent(s) capable of preserving the functionality of epithelial stem cells |
| 08/15/2013 | WO2013117287A1 Method and container for loading a test strip meter with a single test strip |
| 08/15/2013 | WO2013117233A1 Assay and method for determining insulin-resistance |
| 08/15/2013 | WO2013116953A1 Instrument and method for testing fibers |
| 08/15/2013 | WO2013116931A1 Dual-acceptor time-resolved-fret |
| 08/15/2013 | WO2013096822A3 Test device for optical and electrochemical assays |
| 08/15/2013 | WO2013093942A3 Method and device for moisture determination and control |
| 08/15/2013 | WO2013093817A3 Optical method and device for identifying and quantifying analytes |
| 08/15/2013 | WO2013093489A3 Detection and treatment of breast cancer |
| 08/15/2013 | WO2013089868A3 Neuronal biosensor for detection of toxins |
| 08/15/2013 | WO2013082463A3 Assays, antibodies, immunogens and compositions related to 5-fu |
| 08/15/2013 | WO2013078250A3 Cystine knot peptides that bind alpha-v-beta-6 integrin |
| 08/15/2013 | WO2013076501A3 Screening method for identifying agents useful in the treatment and/or prevention of a disease associated with insulin resistance and/or glucose intolerance |
| 08/15/2013 | WO2013075055A3 Kits and methods for assessing appendicitis |
| 08/15/2013 | WO2013074676A3 Assays for selecting a treatment regimen for a subject with depression and methods for treatment |
| 08/15/2013 | WO2013052946A3 Genetically encoded biosensors |
| 08/15/2013 | WO2012141831A9 Devices and methods for infrared (ir) based quantitation of biomolecules |
| 08/15/2013 | US20130212721 Reagent for tumor testing and pharmaceutical composition for tumor prevention |
| 08/15/2013 | US20130212720 Biomarkers associated with autoimmune diseases of the lung |
| 08/15/2013 | US20130212716 PFKs as Modifiers of the IGFR Pathway and Methods of Use |
| 08/15/2013 | US20130212715 Biomarkers for Hematologic Malignacies |
| 08/15/2013 | US20130211061 Method and compositions for the identification of agents that have a potential effect against chronic inflammatory diseases |
| 08/15/2013 | US20130210875 Novel binding site of IKK-beta |
| 08/15/2013 | US20130210779 Method of identifying triple negative breast cancer |
| 08/15/2013 | US20130210731 Compositions and methods to control angiogenesis with cupredoxins |
| 08/15/2013 | US20130210718 Biomarkers for Cardiodiabetes |
| 08/15/2013 | US20130210678 Moesin fragments and uses thereof |
| 08/15/2013 | US20130210677 Reagents and methods for use in cancer diagnosis, classification and therapy |
| 08/15/2013 | US20130210673 Polypeptide Display Libraries and Methods of Making and Using Thereof |
| 08/15/2013 | US20130210671 Immunoreactive antigens of mycoplasma heamofelis and diagnostic immunoassay |
| 08/15/2013 | US20130210669 Device and methods for the immunological identification of cerebrospinal fluid |
| 08/15/2013 | US20130210667 Biomarkers for Predicting Kidney and Glomerular Pathologies |
| 08/15/2013 | US20130210666 Markers of the Male Urogenital Tract |
| 08/15/2013 | US20130210665 Method and kit for the diagnosis and/or prognosis of tolerance in liver transplantation |
| 08/15/2013 | US20130210664 Methods for the Identification of Methyltransferase Interacting Molecules and for the Purification of Methyltransferase Proteins |
| 08/15/2013 | US20130210663 Methods and compounds for the diagnosis and treatment of cancer |
| 08/15/2013 | US20130210662 Detection of target metabolites |
| 08/15/2013 | US20130210661 Markers of vulnerability of the atherosclerosis plaque |
| 08/15/2013 | US20130210656 Late-pcr |
| 08/15/2013 | US20130210654 Multiplex Immune Effector Molecule Assay |
| 08/15/2013 | US20130210652 Nanotechnology enabled point of care testing device |
| 08/15/2013 | US20130210651 Borrelia Diagnostics and Screening Methods |
| 08/15/2013 | US20130210648 Ratio based biomarkers and methods of use thereof |
| 08/15/2013 | US20130210647 Methods of Detecting Cardiovascular Diseases or Conditions |
| 08/15/2013 | US20130210168 Assay for detecting free light chains by capillary zone electrophoresis |
| 08/15/2013 | US20130210167 Immunoassay for pyrrolidinophenones |